Akèy › Dematit atopik (Ekzema) › New York
Etid klinik pou Dematit atopik (Ekzema) nan New York
16 etid pou Dematit atopik (Ekzema) ap chèche patisipan nan sit nan New York.
Vil nan New York
Tèks ofisyèl etid la (Anglè)
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
- OptiSkin Medical, New York
- Equity Medical, LLC, The Bronx
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 72 · Tout sèks · Mizajou Sep 29, 2026 · NCT06808477Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Brooklyn
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, New York
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT07298395A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Montefiore - Jacobi Dermatology Clinic, The Bronx
- Montefiore - Clinical Research Center, The Bronx
- Montefiore - Greene Medical Arts Pavillion, The Bronx
- ak 2 plis
Ap rekriteFaz 2
Laj 18 a 64 · Tout sèks · Mizajou Sep 25, 2026 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07003425Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
- Weill Cornell Medicine, New York
- Columbia University Irving Medical Center, New York
Ap rekrite
Laj 13 a 17 · Tout sèks · Mizajou Sep 8, 2026 · NCT07746427A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Sadick Research Group, LLC, New York
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Aug 28, 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 6, Kew Gardens
- Inmagene Site 21, New York
- Inmagene Site 11, Woodbury
Ap rekriteFaz 2
Laj 18 a 74 · Tout sèks · Mizajou Aug 12, 2026 · NCT07037901Skin Microbial Ecology in Atopic Dermatitis
- University of Rochester Medical Center, Rochester
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 13 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT04170244A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Equity Medical /ID# 265814, New York
- Weill Cornell Medicine /ID# 265793, New York
Ap rekriteFaz 3
Laj 18 a 63 · Tout sèks · Mizajou Jul 6, 2026 · NCT06389136Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
- Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, New York
- University of Rochester Medical Center: Department of Dermatology, Rochester
Ap rekriteFaz 1
Laj 6 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT06504160A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Empire Dermatology, East Syracuse
- Private Practice - Dr. Bobby Buka, New York
- Icahn School of Medicine at Mount Sinai, New York
- ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 4, 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site - Site 7080, Auburn
- Galderma Investigational Site # 7052, East Syracuse
- Galderma Investigational Site - 8282, Mount Kisco
- ak 3 plis
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT06988605Allergy and Immunology Natural History Study
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Jiska laj 99 · Tout sèks · Mizajou Feb 4, 2026 · NCT05584488Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
- Icahn School of Medicine at Mount Sinai, New York
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Feb 2, 2026 · NCT07242638A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
- Pfizer, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 0 ak plis · Fanm · Mizajou Dec 9, 2025 · NCT05721937Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.